dibenz[a,h]anthracene - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	dibenz[a,h]anthracene	go back to main search page
Accession:	CHEBI:35299	browse the term
Definition:	An ortho-fused polycyclic arene that has formula C22H14.
Synonyms:	related_synonym:	1,2:5,6-Dibenzanthracene; DBA; Formula=C22H14; InChI=1S/C22H14/c1-3-7-19-15(5-1)9-11-17-14-22-18(13-21(17)19)12-10-16-6-2-4-8-20(16)22/h1-14H; InChIKey=LHRCREOYAASXPZ-UHFFFAOYSA-N; SMILES=c1ccc2c(c1)ccc1cc3c(ccc4ccccc34)cc21
	alt_id:	CHEBI:18901; CHEBI:34684
	xref:	CAS:53-70-3; KEGG:C14325
	xref_mesh:	MESH:C026486

show annotations for term's descendants Sort by:
Rat (840) Mouse (897) Human (849) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (840)

dibenz[a,h]anthracene

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha-2-macroglobulin

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of A2M mRNA

NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786

G

alanine and arginine rich domain containing protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AARD mRNA

NCBI chr 7:83,364,478...83,369,319
Ensembl chr 7:83,364,204...83,369,317

G

ATP binding cassette subfamily A member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCA1 mRNA

NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170

G

ATP binding cassette subfamily B member 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCB1A mRNA

NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709

G

ATP-binding cassette, sub-family B member 1B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCB1B mRNA

NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199

G

ATP binding cassette subfamily B member 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCB4 mRNA

NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202

G

ATP binding cassette subfamily C member 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ABCC3 mRNA

NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595

G

ATP binding cassette subfamily D member 3

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of ABCD3 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ABCD3 mRNA

NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020

G

ATP binding cassette subfamily G member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABCG5 mRNA

NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563

G

abhydrolase domain containing 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABHD15 mRNA

NCBI chr10:62,363,209...62,368,600
Ensembl chr10:62,363,209...62,368,600

G

abhydrolase domain containing 5, lysophosphatidic acid acyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABHD5 mRNA

NCBI chr 8:122,000,241...122,026,447
Ensembl chr 8:122,000,389...122,026,447

G

ABI family, member 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABI3 mRNA

NCBI chr10:80,769,819...80,780,816
Ensembl chr10:80,769,822...80,780,816

G

ABI family member 3 binding protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ABI3BP mRNA

NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929

G

actin-binding LIM protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ABLIM1 mRNA

NCBI chr 1:256,083,747...256,372,075
Ensembl chr 1:256,084,297...256,371,969

G

atypical chemokine receptor 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ACKR4 mRNA

NCBI chr 8:104,716,537...104,720,972
Ensembl chr 8:104,716,067...104,723,617

G

acyl-CoA thioesterase 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ACOT1 mRNA

NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163

G

acyl-CoA oxidase 2

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of ACOX2 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ACOX2 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ACOX2 mRNA

NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160

G

acyl-CoA oxidase-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ACOXL mRNA

NCBI chr 3:115,061,069...115,367,032
Ensembl chr 3:115,061,060...115,364,686

G

activin A receptor type 2B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ACVR2B mRNA

NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458

G

ADAM metallopeptidase domain 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADAM15 mRNA

NCBI chr 2:174,754,629...174,765,136
Ensembl chr 2:174,754,633...174,765,113

G

ADAM-like, decysin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADAMDEC1 mRNA

NCBI chr15:42,900,629...42,921,684
Ensembl chr15:42,900,636...42,921,712

G

ADAMTS-like 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADAMTSL2 mRNA

NCBI chr 3:10,397,774...10,434,557
Ensembl chr 3:10,404,626...10,434,554

G

adenosine deaminase, tRNA-specific 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ADAT3 mRNA

NCBI chr 7:9,109,070...9,113,673
Ensembl chr 7:9,101,187...9,115,340

G

adhesion G protein-coupled receptor L4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADGRL4 mRNA

NCBI chr 2:240,354,909...240,457,231
Ensembl chr 2:240,354,941...240,457,225

G

adrenomedullin

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ADM mRNA

NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654

G

ADP-ribosylarginine hydrolase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ADPRH mRNA

NCBI chr11:62,299,831...62,306,170
Ensembl chr11:62,299,793...62,306,931

G

adrenoceptor beta 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADRB1 mRNA

NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259

G

adrenoceptor beta 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ADRB2 mRNA

NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512

G

apoptosis enhancing nuclease

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AEN mRNA

NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523

G

AFG1 like ATPase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AFG1L mRNA

NCBI chr20:45,798,344...45,967,997
Ensembl chr20:45,798,349...45,967,906

G

angiotensin II receptor, type 1a

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AGTR1A mRNA

NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946

G

adenosylhomocysteinase-like 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of AHCYL2 mRNA

NCBI chr 4:58,381,290...58,531,061
Ensembl chr 4:58,381,218...58,531,060

G

aryl hydrocarbon receptor

affects response to substance
multiple interactions
affects localization
affects binding
increases activity

AHR affects the susceptibility to 1,2,5,6-dibenzanthracene
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene binds to AHR protein]; 1,2,5,6-dibenzanthracene binds to and results in increased activity of AHR protein; 1,2,5,6-dibenzanthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]
1,2,5,6-dibenzanthracene affects the localization of AHR protein
1,2,5,6-dibenzanthracene binds to AHR protein
1,2,5,6-dibenzanthracene results in increased activity of AHR protein
1,2,5,6-dibenzanthracene binds to and results in increased activity of AHR protein; 1,2,5,6-dibenzanthracene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; 1,2,5,6-dibenzanthracene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; [acenaphthene co-treated with anthracene co-treated with 1,12-benzoperylene co-treated with 1,2,5,6-dibenzanthracene co-treated with fluorene co-treated with naphthalene co-treated with phenanthrene] results in increased activity of AHR protein; [benz(a)anthracene co-treated with Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene co-treated with pyrene] results in increased activity of AHR protein; sulforaphane inhibits the reaction [1,2,5,6-dibenzanthracene affects the localization of AHR protein]

PMID:3005314 PMID:3011254 PMID:3024361 PMID:6322977 PMID:11525907 More...

NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568

G

aryl-hydrocarbon receptor repressor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AHRR mRNA

NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673

G

AIF family member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AIFM2 mRNA

NCBI chr20:29,654,283...29,679,239
Ensembl chr20:29,652,927...29,679,236

G

adenylate kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AK1 mRNA

NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041

G

adenylate kinase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AK4 mRNA

NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618

G

aldo-keto reductase family 1 member B1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AKR1B1 mRNA
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of AKR1B1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of AKR1B1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AKR1B1 mRNA

PMID:17690111 PMID:18711122

NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157

G

aldo-keto reductase family 1, member C1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AKR1C1 mRNA

NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326

G

aldolase, fructose-bisphosphate B

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ALDOB mRNA

NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116

G

alkaline phosphatase, biomineralization associated

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ALPL mRNA

NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446

G

alsin Rho guanine nucleotide exchange factor ALS2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ALS2 mRNA

NCBI chr 9:60,613,182...60,686,394
Ensembl chr 9:60,613,167...60,670,737

G

alpha-methylacyl-CoA racemase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of AMACR mRNA

NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255

G

anillin, actin binding protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ANLN mRNA

NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538

G

annexin A8

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ANXA8 mRNA

NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043

G

apolipoprotein C3

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of APOC3 mRNA

NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583

G

apolipoprotein D

increases expression

1,2,5,6-dibenzanthracene results in increased expression of APOD mRNA

NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305

G

adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of APPL1 mRNA

NCBI chr16:2,118,503...2,166,741
Ensembl chr16:2,121,255...2,166,692

G

aquaporin 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of AQP1 mRNA

NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690

G

androgen receptor

increases activity
multiple interactions

1,2,5,6-dibenzanthracene results in increased activity of AR protein
1,2,5,6-dibenzanthracene affects the reaction [Androgens results in increased activity of AR protein]; 1,2,5,6-dibenzanthracene binds to and results in increased activity of AR protein

PMID:10771140 PMID:28377212 PMID:28803809

NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925

G

arginine and glutamate rich 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARGLU1 mRNA

NCBI chr16:80,753,300...80,777,350
Ensembl chr16:80,753,315...80,777,349

G

Rho GTPase activating protein 26

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ARHGAP26 mRNA

NCBI chr18:30,835,806...31,237,945
Ensembl chr18:30,838,671...31,235,194

G

Rho guanine nucleotide exchange factor 26

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ARHGEF26 mRNA

NCBI chr 2:146,740,336...146,850,918
Ensembl chr 2:146,739,631...146,850,819

G

ADP-ribosylation factor like GTPase 4A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARL4A mRNA

NCBI chr 6:57,079,496...57,084,156
Ensembl chr 6:57,078,812...57,085,066

G

ADP-ribosylation factor like GTPase 4D

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARL4D mRNA

NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836

G

armadillo repeat containing, X-linked 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ARMCX4 mRNA

NCBI chr X:97,860,526...97,870,912
Ensembl chr X:97,860,629...97,870,912

G

arrestin domain containing 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARRDC4 mRNA

NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290

G

arylsulfatase G

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ARSG mRNA

NCBI chr10:94,412,261...94,551,224
Ensembl chr10:94,447,399...94,542,941

G

ADP-ribosyltransferase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ART3 mRNA

NCBI chr14:15,637,230...15,719,442
Ensembl chr14:15,637,237...15,665,407

G

ADP-ribosyltransferase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ART4 mRNA

NCBI chr 4:169,740,331...169,751,571
Ensembl chr 4:169,740,331...169,750,665

G

ArfGAP with SH3 domain, ankyrin repeat and PH domain 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ASAP2 mRNA

NCBI chr 6:40,658,201...40,821,017
Ensembl chr 6:40,657,880...40,820,975

G

anti-silencing function 1B histone chaperone

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ASF1B mRNA

NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549

G

asialoglycoprotein receptor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ASGR1 mRNA

NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631

G

asparagine synthetase (glutamine-hydrolyzing)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ASNS mRNA

NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423

G

aspartoacylase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ASPA mRNA

NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272

G

assembly factor for spindle microtubules

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ASPM mRNA

NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755

G

activating transcription factor 3

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ATF3 mRNA

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631

G

activating transcription factor 5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ATF5 mRNA

NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707

G

autophagy related 4C, cysteine peptidase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ATG4C mRNA

NCBI chr 5:113,867,218...113,935,534
Ensembl chr 5:113,867,092...113,934,830

G

ATPase Na+/K+ transporting subunit alpha 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ATP1A2 mRNA

NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544

G

ATPase, class I, type 8B, member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ATP8B5 mRNA

NCBI chr 5:57,505,897...57,620,065
Ensembl chr 5:57,506,466...57,620,056

G

aurora kinase A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of AURKA mRNA

NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390

G

arginine vasopressin receptor 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of AVPR1A mRNA

NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215

G

beta-secretase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BACE2 mRNA

NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546

G

BAG cochaperone 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BAG3 mRNA

NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858

G

BAR/IMD domain containing adaptor protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BAIAP2 mRNA

NCBI chr10:105,223,065...105,290,130
Ensembl chr10:105,223,090...105,290,134

G

basic leucine zipper ATF-like transcription factor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BATF mRNA

NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051

G

BCL2 associated X, apoptosis regulator

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BAX mRNA

NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368

G

Bcl-2 binding component 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BBC3 mRNA

NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509

G

brevican

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BCAN mRNA

NCBI chr 2:173,454,479...173,467,717
Ensembl chr 2:173,454,482...173,467,460

G

Bcl2-like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BCL2L1 mRNA

NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479

G

BCL3, transcription coactivator

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BCL3 mRNA

NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607

G

BCL6, transcription repressor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BCL6 mRNA

NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389

G

BCL6B, transcription repressor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BCL6B mRNA

NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974

G

BAF chromatin remodeling complex subunit BCL7C

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BCL7C mRNA

NCBI chr 1:182,277,163...182,324,274
Ensembl chr 1:182,260,164...182,324,163

G

brain expressed, associated with NEDD4, 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BEAN1 mRNA

NCBI chr19:739,551...786,395
Ensembl chr19:739,551...787,537

G

basic helix-loop-helix family, member e40

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BHLHE40 mRNA

NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774

G

bridging integrator 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BIN2 mRNA

NCBI chr 7:131,742,001...131,768,208
Ensembl chr 7:131,742,002...131,786,285

G

baculoviral IAP repeat-containing 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BIRC5 mRNA

NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380

G

basic helix-loop-helix ARNT like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BMAL1 mRNA

NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231

G

bone morphogenetic protein receptor type 1B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BMPR1B mRNA

NCBI chr 2:230,538,252...230,871,077
Ensembl chr 2:230,541,558...230,871,368

G

BCL2 interacting protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BNIP3 mRNA

NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359

G

BCL2 family apoptosis regulator BOK

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BOK mRNA

NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476

G

bone marrow stromal cell antigen 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of BST2 mRNA

NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979

G

BTG anti-proliferation factor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of BTG1 mRNA

NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649

G

complement C1q B chain

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of C1QB mRNA

NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407

G

C1q and TNF related 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of C1QTNF2 mRNA

NCBI chr10:27,941,948...27,958,926
Ensembl chr10:27,941,948...27,959,185

G

C1q and TNF related 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of C1QTNF5 mRNA

NCBI chr 8:44,450,934...44,453,075
Ensembl chr 8:44,451,154...44,453,074

G

C1q and TNF related 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of C1QTNF7 mRNA

NCBI chr14:67,467,888...67,580,477
Ensembl chr14:67,468,014...67,580,410

G

complement C5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HC mRNA

NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994

G

carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CAD mRNA

NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861

G

calcitonin receptor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CALCR mRNA

NCBI chr 4:31,661,270...31,736,392
Ensembl chr 4:31,661,273...31,736,392

G

calpain 8

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CAPN8 mRNA

NCBI chr13:94,252,218...94,316,146
Ensembl chr13:94,253,054...94,316,146

G

cell cycle associated protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CAPRIN1 mRNA

NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502

G

carbonic anhydrase 3

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CA3 mRNA
1,2,5,6-dibenzanthracene results in decreased expression of CAR3 mRNA

PMID:17690111 PMID:26377693

NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280

G

carbonic anhydrase 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CAR8 mRNA

NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374

G

calcium regulated heat stable protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CARHSP1 mRNA

NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019

G

caspase 3

increases activity

1,2,5,6-dibenzanthracene results in increased activity of CASP3 protein

NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648

G

caspase 7

increases activity

1,2,5,6-dibenzanthracene results in increased activity of CASP7 protein

NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729

G

coiled-coil domain containing 162

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CCDC162 mRNA

NCBI chr20:45,044,891...45,237,905
Ensembl chr20:45,032,752...45,236,193

G

coiled-coil domain containing 184

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCDC184 mRNA

NCBI chr 7:129,297,635...129,301,961
Ensembl chr 7:129,298,212...129,304,494

G

C-C motif chemokine ligand 19

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCL19 mRNA

NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308

G

CCM2 like scaffold protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCM2L mRNA

NCBI chr 3:141,533,470...141,549,136
Ensembl chr 3:141,533,511...141,549,140

G

cellular communication network factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN1 mRNA

NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484

G

cellular communication network factor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN2 mRNA

NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734

G

cellular communication network factor 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN4 mRNA

NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248

G

cellular communication network factor 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCN5 mRNA

NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636

G

cyclin A2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNA2 mRNA

NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577

G

cyclin B1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CCNB1 mRNA

NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172

G

cyclin B2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNB2 mRNA

NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874

G

cyclin D1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCND1 mRNA

NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602

G

cyclin F

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNF mRNA

NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101

G

cyclin G1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CCNG1 mRNA

NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641

G

cyclin J-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CCNJL mRNA

NCBI chr10:27,995,682...28,053,428
Ensembl chr10:27,995,679...28,053,426

G

C-C motif chemokine receptor 2

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CCR2 mRNA

NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100

G

CD151 molecule (Raph blood group)

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD151 mRNA

NCBI chr 1:196,564,744...196,568,753
Ensembl chr 1:196,565,181...196,568,753

G

CD1d1 molecule

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD1D1 mRNA

NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089

G

Cd200 molecule

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD200 mRNA

NCBI chr11:55,410,166...55,437,527
Ensembl chr11:55,410,196...55,501,648

G

CD24 molecule

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD24A mRNA

NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662

G

CD34 molecule

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD34 mRNA

NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832

G

CD38 molecule

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CD38 mRNA

NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986

G

Cd63 molecule

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD63 protein

NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178

G

Cd81 molecule

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CD81 protein

NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660

G

cell division cycle 20

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDC20 mRNA

NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512

G

cell division cycle associated 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDCA5 mRNA

NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023

G

cell division cycle associated 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDCA8 mRNA

NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629

G

cadherin 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CDH1 mRNA

NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775

G

cadherin 17

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CDH17 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CDH17 mRNA

NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884

G

cyclin-dependent kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDK1 mRNA

NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408

G

cyclin-dependent kinase inhibitor 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDKN1A mRNA

NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585

G

cyclin-dependent kinase inhibitor 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDKN3 mRNA

NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945

G

chromatin licensing and DNA replication factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CDT1 mRNA

NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659

G

CCAAT/enhancer binding protein beta

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CEBPB mRNA

NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473

G

CUGBP, Elav-like family member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CELF5 mRNA

NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322

G

cell migration inducing hyaluronidase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CEMIP2 mRNA

NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760

G

centromere protein E

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CENPE mRNA

NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669

G

centromere protein K

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CENPK mRNA

NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706

G

carboxylesterase 2E

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CES2E mRNA

NCBI chr19:157,447...172,822
Ensembl chr19:157,407...172,856

G

carboxylesterase 2H

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CES2 mRNA

NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830

G

cilia and flagella associated protein 69

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CFAP69 mRNA

NCBI chr 4:28,379,604...28,452,562
Ensembl chr 4:28,375,996...28,450,698

G

complement factor D

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CFD mRNA

NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053

G

CASP8 and FADD-like apoptosis regulator

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CFLAR mRNA

NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034

G

cell growth regulator with EF hand domain 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CGREF1 mRNA

NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852

G

chromatin assembly factor 1 subunit B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CHAF1B mRNA

NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070

G

chromodomain helicase DNA binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CHD2 mRNA

NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502

G

choline kinase alpha

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CHKA mRNA

NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516

G

chimerin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CHN2 mRNA

NCBI chr 4:83,148,616...83,407,711
Ensembl chr 4:83,147,983...83,407,709

G

cysteine and histidine rich domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CHORDC1 mRNA

NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162

G

ciliary microtubule associated protein 1B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CIMAP1B mRNA

NCBI chr 7:120,444,232...120,447,294
Ensembl chr 7:120,444,232...120,446,749

G

ciliary microtubule inner protein 2B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CIMIP2B mRNA

NCBI chr 5:57,675,537...57,680,133
Ensembl chr 5:57,675,462...57,678,611

G

cytokine inducible SH2-containing protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CISH mRNA

NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250

G

cytoskeleton associated protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CKAP2 mRNA

NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913

G

CDC28 protein kinase regulatory subunit 1B

affects expression

1,2,5,6-dibenzanthracene affects the expression of CKS1B mRNA

NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636

G

chloride voltage-gated channel 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CLCN2 mRNA

NCBI chr11:80,197,741...80,211,657
Ensembl chr11:80,198,153...80,211,657

G

claudin 7

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CLDN7 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CLDN7 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CLDN7 mRNA

NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171

G

claudin domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLDND1 mRNA

NCBI chr11:41,883,120...41,889,471
Ensembl chr11:41,883,134...41,889,354

G

C-type lectin domain family 1, member A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CLEC1A mRNA

NCBI chr 4:162,875,360...162,902,571
Ensembl chr 4:162,877,346...162,901,247

G

C-type lectin domain family 1, member B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLEC1B mRNA

NCBI chr 4:162,847,978...162,856,291
Ensembl chr 4:162,848,010...162,856,291

G

C-type lectin domain family 4, member D

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLEC4D mRNA

NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848

G

calmin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CLMN mRNA

NCBI chr 6:123,707,710...123,807,283
Ensembl chr 6:123,713,507...123,807,272

G

clock circadian regulator

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLOCK mRNA

NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400

G

caseinolytic mitochondrial matrix peptidase chaperone subunit X

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLPX mRNA

NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082

G

calsyntenin 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CLSTN3 mRNA

NCBI chr 4:157,331,494...157,364,769
Ensembl chr 4:157,331,494...157,364,769

G

CKLF-like MARVEL transmembrane domain containing 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CMTM4 mRNA

NCBI chr19:576,203...616,109
Ensembl chr19:576,203...616,109

G

collagen type IV alpha 1 chain

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COL4A1 mRNA

NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412

G

collagen type IV alpha 2 chain

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COL4A2 mRNA

NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839

G

collagen type V alpha 3 chain

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of COL5A3 mRNA

NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853

G

collagen like tail subunit of asymmetric acetylcholinesterase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of COLQ mRNA

NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107

G

COMM domain containing 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COMMD3 mRNA

NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177

G

coenzyme Q10B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of COQ10B mRNA

NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663

G

ceruloplasmin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CP mRNA

NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075

G

carboxypeptidase E

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CPE mRNA

NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233

G

calcineurin-like phosphoesterase domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CPPED1 mRNA

NCBI chr10:3,701,522...3,821,050
Ensembl chr10:3,701,459...3,821,054

G

ceramide-1-phosphate transfer protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CPTP mRNA

NCBI chr 5:166,474,947...166,479,103
Ensembl chr 5:166,474,966...166,479,017

G

cellular retinoic acid binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CRABP2 mRNA

NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379

G

cAMP responsive element binding protein-like 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CREBL2 mRNA

NCBI chr 4:167,673,359...167,699,299
Ensembl chr 4:167,673,315...167,699,292

G

CREB/ATF bZIP transcription factor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CREBZF mRNA

NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553

G

cytokine receptor-like factor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CRLF2 mRNA

NCBI chr14:103,943...108,643
Ensembl chr14:103,939...108,642

G

carnitine O-octanoyltransferase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CROT mRNA

NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109

G

cryptochrome circadian regulator 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CRY2 mRNA

NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965

G

crystallin, mu

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CRYM mRNA

NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633

G

colony stimulating factor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CSF1 mRNA

NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704

G

catenin delta 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CTNND2 mRNA

NCBI chr 2:81,168,525...82,016,495
Ensembl chr 2:81,167,117...82,015,764

G

C-X3-C motif chemokine ligand 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CX3CL1 mRNA

NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833

G

C-X-C motif chemokine ligand 12

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CXCL12 mRNA

NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168

G

cytochrome b5 type A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYB5A mRNA

NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535
Ensembl chr18:78,202,342...78,258,535

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions
increases activity
increases expression
decreases expression
affects expression

1,2,5,6-dibenzanthracene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; 2-oxohexyl isothiocyanate inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A1 mRNA; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; alyssin inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; Cadmium Chloride inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; lead nitrate inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; sodium arsenite inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; TP53 protein affects the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 protein]
[CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]
CYP1A1 protein results in increased activity of 1,2,5,6-dibenzanthracene
1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 protein
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene affects the expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [dibenzo(a,l)pyrene results in increased expression of CYP1A1 mRNA]; 1,2,5,6-dibenzanthracene promotes the reaction [fluoranthene results in increased expression of CYP1A1 mRNA]; Benzo(a)pyrene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]; dibenzo(a,l)pyrene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]; fluoranthene promotes the reaction [1,2,5,6-dibenzanthracene results in increased expression of CYP1A1 mRNA]
1,2,5,6-dibenzanthracene results in decreased expression of CYP1A1 mRNA
1,2,5,6-dibenzanthracene affects the expression of CYP1A1 mRNA

PMID:8961944 PMID:10190573 PMID:11162773 PMID:11408366 PMID:11955671 More...

NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125

G

cytochrome P450, family 1, subfamily a, polypeptide 2

multiple interactions
increases activity
increases metabolic processing
decreases activity
increases expression

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-1,2-dihydrodiol; [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol; alyssin inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; sulforaphane inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]
[CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]
1,2,5,6-dibenzanthracene results in decreased activity of CYP1A2 protein
1,2,5,6-dibenzanthracene results in increased expression of CYP1A2 mRNA
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA

PMID:8638931 PMID:8961944 PMID:11162773 PMID:16269432 PMID:17253728 More...

NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312

G

cytochrome P450, family 1, subfamily b, polypeptide 1

increases expression
affects expression
multiple interactions
increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 mRNA
1,2,5,6-dibenzanthracene affects the expression of CYP1B1 mRNA
1,2,5,6-dibenzanthracene affects the reaction [Benzo(a)pyrene affects the expression of CYP1B1 mRNA]
1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of CYP1B1 protein
dibenz[a,h]anthracene increases expression of CYP1B1 mRNA in lung epithelial cell

CTD
RGD

PMID:11955671 PMID:12117779 PMID:17253728 PMID:17961608 PMID:19358281 More...

NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917

G

cytochrome P450, family 26, subfamily b, polypeptide 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CYP26B1 mRNA

NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628

G

cytochrome P450, family 2, subfamily b, polypeptide 3

increases metabolic processing
multiple interactions

CYP2B6 protein results in increased metabolism of 1,2,5,6-dibenzanthracene
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP2B6 mRNA; [CYP2B6 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol

PMID:8638931 PMID:17690111

NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143

G

cytochrome P450, family 2, subfamily d, polypeptide 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYP2D6 mRNA

NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759

G

cytochrome P450, family 2, subfamily e, polypeptide 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYP2E1 mRNA

NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023

G

cytochrome P450, family 2, subfamily s, polypeptide 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of CYP2S1 mRNA

NCBI chr 1:81,309,948...81,325,303
Ensembl chr 1:81,310,451...81,325,303

G

cytochrome P450 family 7 subfamily B member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYP7B1 mRNA

NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698

G

cystin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYS1 mRNA

NCBI chr 6:41,300,836...41,318,071
Ensembl chr 6:41,300,836...41,318,071

G

cysteine and tyrosine rich 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of CYYR1 mRNA

NCBI chr11:24,557,620...24,664,007
Ensembl chr11:24,515,316...24,663,961

G

dachshund family transcription factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DACH1 mRNA

NCBI chr15:74,528,122...74,909,811
Ensembl chr15:74,529,208...74,909,922

G

diazepam binding inhibitor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DBI mRNA

NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693

G

D-box binding PAR bZIP transcription factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DBP mRNA

NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745

G

DDB1 and CUL4 associated factor 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DCAF4 mRNA

NCBI chr 6:103,154,847...103,180,992
Ensembl chr 6:103,154,867...103,180,982

G

dachsous cadherin-related 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DCHS1 mRNA

NCBI chr 1:160,104,931...160,138,958
Ensembl chr 1:160,104,931...160,124,808

G

DNA cross-link repair 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DCLRE1A mRNA

NCBI chr 1:255,569,911...255,589,815
Ensembl chr 1:255,569,919...255,589,678

G

dimethylarginine dimethylaminohydrolase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDAH1 mRNA

NCBI chr 2:234,667,499...234,800,322
Ensembl chr 2:234,667,491...234,799,339

G

DNA damage-induced apoptosis suppressor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDIAS mRNA

NCBI chr 1:146,906,150...146,930,462
Ensembl chr 1:146,906,154...146,930,462

G

DNA-damage inducible transcript 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DDIT3 mRNA

NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201

G

DNA-damage-inducible transcript 4-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDIT4L mRNA

NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375

G

D-aspartate oxidase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DDO mRNA

NCBI chr20:44,090,823...44,109,962
Ensembl chr20:44,090,914...44,133,095

G

death effector domain containing 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DEDD2 mRNA

NCBI chr 1:80,789,084...80,807,789
Ensembl chr 1:80,792,000...80,807,714

G

DENN domain containing 2B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DENND2B mRNA

NCBI chr 1:163,544,075...163,734,736
Ensembl chr 1:163,544,074...163,694,680

G

desumoylating isopeptidase 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DESI2 mRNA

NCBI chr13:89,961,767...90,011,255
Ensembl chr13:89,961,934...90,016,416

G

desert hedgehog signaling molecule

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DHH mRNA

NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406

G

dispatched RND transporter family member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DISP2 mRNA

NCBI chr 3:105,762,303...105,777,826
Ensembl chr 3:105,762,305...105,777,800

G

dynein, axonemal, intermediate chain 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAI1 mRNA

NCBI chr 5:56,730,179...56,800,926
Ensembl chr 5:56,730,179...56,800,925

G

dynein axonemal intermediate chain 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAI4 mRNA

NCBI chr 5:117,787,398...117,876,216
Ensembl chr 5:117,788,464...117,876,127

G

DnaJ heat shock protein family (Hsp40) member A1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAJA1 mRNA

NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967

G

DnaJ heat shock protein family (Hsp40) member B1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNAJB1 mRNA

NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458

G

DNA methyltransferase 3 beta

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNMT3B mRNA

NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124

G

deoxynucleotidyltransferase, terminal, interacting protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DNTTIP1 mRNA

NCBI chr 3:153,481,718...153,505,403
Ensembl chr 3:153,481,705...153,505,759

G

desmoplakin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DSP mRNA

NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800

G

deltex E3 ubiquitin ligase 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of DTX4 mRNA

NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818

G

dual specificity phosphatase 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of DUSP1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of DUSP1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of DUSP1 mRNA

NCBI chr10:16,680,478...16,683,275

G

dual specificity tyrosine phosphorylation regulated kinase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DYRK3 mRNA

NCBI chr13:42,594,120...42,604,898
Ensembl chr13:42,594,121...42,604,778

G

dysferlin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of DYSF mRNA

NCBI chr 4:116,490,877...116,690,709
Ensembl chr 4:116,490,616...116,690,709

G

E2F transcription factor 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of E2F7 mRNA

NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734

G

E2F transcription factor 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of E2F8 mRNA

NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098

G

endothelin converting enzyme 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ECE1 mRNA

NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371

G

extracellular matrix protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ECM1 mRNA

NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671

G

endothelin receptor type B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EDNRB mRNA

NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115

G

ephrin A1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EFNA1 mRNA

NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866

G

ephrin B2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EFNB2 mRNA

NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391

G

early growth response 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EGR1 mRNA

NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766

G

enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of EHHADH mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of EHHADH mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of EHHADH mRNA

NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188

G

EI24, autophagy associated transmembrane protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EI24 mRNA

NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571

G

endomucin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EMCN mRNA

NCBI chr 2:225,891,100...225,970,932
Ensembl chr 2:225,891,100...225,970,929

G

EMI domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EMID1 mRNA

NCBI chr14:80,000,486...80,043,561
Ensembl chr14:80,000,486...80,043,620

G

epithelial membrane protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EMP1 mRNA

NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904

G

enkurin, TRPC channel interacting protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ENKUR mRNA

NCBI chr17:83,690,105...83,714,756
Ensembl chr17:83,690,797...83,714,408

G

erythrocyte membrane protein band 4.1 like 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EPB41L5 mRNA

NCBI chr13:30,670,792...30,770,213
Ensembl chr13:30,669,764...30,768,360

G

Eph receptor A4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EPHA4 mRNA

NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139

G

Eph receptor B6

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of EPHB6 mRNA

NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230

G

epoxide hydrolase 1

multiple interactions
increases expression

EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene]
1,2,5,6-dibenzanthracene results in increased expression of EPHX1 mRNA

PMID:8961944 PMID:26377693

NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235

G

erb-b2 receptor tyrosine kinase 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ERBB2 mRNA

NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078

G

glutamate-rich 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ERICH3 mRNA

NCBI chr 2:243,615,777...243,717,973
Ensembl chr 2:243,615,872...243,715,317

G

endothelial cell-specific molecule 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ESM1 mRNA

NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804

G

estrogen related receptor, alpha

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ESRRA mRNA

NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268

G

ETHE1, persulfide dioxygenase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ETHE1 mRNA

NCBI chr 1:80,184,037...80,199,092
Ensembl chr 1:80,183,894...80,199,052

G

eva-1 homolog A, regulator of programmed cell death

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EVA1A mRNA

NCBI chr 4:114,593,773...114,643,011
Ensembl chr 4:114,593,341...114,643,011

G

exocyst complex component 3-like 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EXOC3L2 mRNA

NCBI chr 1:79,113,784...79,145,359
Ensembl chr 1:79,112,506...79,145,465

G

exocyst complex component 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of EXOC4 mRNA

NCBI chr 4:61,807,706...62,584,316
Ensembl chr 4:61,807,761...62,585,723

G

coagulation factor III, tissue factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of F3 mRNA

NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668

G

fatty acid binding protein 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FABP1 mRNA

NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788

G

family with sequence similarity 107, member A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM107A mRNA

NCBI chr15:16,608,362...16,630,398
Ensembl chr15:16,607,205...16,630,396

G

family with sequence similarity 169, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM169B mRNA

NCBI chr 1:121,878,670...121,968,272
Ensembl chr 1:121,878,713...121,958,470

G

family with sequence similarity 181, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM181B mRNA

NCBI chr 1:147,166,428...147,167,925
Ensembl chr 1:147,124,740...147,168,298
Ensembl chr 1:147,124,740...147,168,298

G

family with sequence similarity 53, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM53B mRNA

NCBI chr 1:187,500,061...187,591,186
Ensembl chr 1:187,500,066...187,591,186

G

family with sequence similarity 76, member A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FAM76A mRNA

NCBI chr 5:145,107,491...145,135,734
Ensembl chr 5:145,107,491...145,135,574

G

fatty acid synthase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FASN mRNA

NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261

G

fibulin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FBLN1 mRNA

NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075

G

F-box protein 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FBXO5 mRNA

NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437

G

flap structure-specific endonuclease 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FEN1 mRNA

NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003

G

fibrinogen alpha chain

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FGA mRNA

NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528

G

fibroblast growth factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGF1 mRNA

NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357

G

fibroblast growth factor 9

increases expression
increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGF9 mRNA
dibenz[a,h]anthracene increases expression of FGF9 mRNA in lung epithelial cell

CTD
RGD

PMID:19358281 PMID:19358281

NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309

G

fibroblast growth factor receptor 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGFR3 mRNA

NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341

G

fibrinogen gamma chain

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FGG mRNA

NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322

G

fibrinogen-like 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FGL2 mRNA

NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207

G

four and a half LIM domains 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of FHL1 mRNA

NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928

G

fin bud initiation factor homolog

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of FIBIN mRNA

NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676

G

fidgetin-like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FIGNL1 mRNA

NCBI chr14:86,368,670...86,381,728
Ensembl chr14:86,368,675...86,377,455

G

filamin B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FLNB mRNA

NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006

G

flavin containing dimethylaniline monoxygenase 1

affects expression

1,2,5,6-dibenzanthracene affects the expression of FMO1 mRNA

NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647

G

flavin containing dimethylaniline monoxygenase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FMO2 mRNA

NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308

G

flavin containing dimethylaniline monoxygenase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FMO3 mRNA

NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028

G

flavin containing dimethylaniline monoxygenase 5

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FMO5 mRNA

NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693

G

fibronectin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FN1 mRNA

NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678

G

forkhead box A2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FOXA2 mRNA

NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326

G

forkhead box F2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FOXF2 mRNA

NCBI chr17:32,835,730...32,842,547
Ensembl chr17:32,836,777...32,842,176

G

ferric-chelate reductase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FRRS1 mRNA

NCBI chr 2:204,820,898...204,881,487
Ensembl chr 2:204,823,025...204,895,540

G

frizzled class receptor 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of FZD6 mRNA

NCBI chr 7:70,055,012...70,086,781
Ensembl chr 7:70,055,068...70,086,776

G

glucose-6-phosphate dehydrogenase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of G6PD mRNA

NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801

G

growth arrest and DNA-damage-inducible, alpha

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GADD45A mRNA

NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115

G

polypeptide N-acetylgalactosaminyltransferase 12

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GALNT12 mRNA

NCBI chr 5:61,384,575...61,413,346
Ensembl chr 5:61,384,571...61,413,354

G

growth associated protein 43

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GAP43 mRNA

NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045

G

golgi associated RAB2 interactor 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GARIN1A mRNA

NCBI chr 4:57,880,019...57,890,824
Ensembl chr 4:57,880,019...57,890,820

G

golgi associated kinase 1B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GASK1B mRNA

NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477

G

GATA binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GATA2 mRNA

NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761

G

guanylate binding protein 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GBP4 mRNA

NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879

G

guanylate binding protein 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GBP5 mRNA

NCBI chr 2:231,237,748...231,257,071
Ensembl chr 2:231,237,748...231,257,061

G

guanylate binding protein family member 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GBP6 mRNA

NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062
Ensembl chr14:4,730,453...4,839,062

G

glucokinase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of GCK mRNA

NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995

G

growth differentiation factor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GDF1 mRNA

NCBI chr16:19,097,309...19,112,519
Ensembl chr16:19,097,314...19,112,519

G

growth differentiation factor 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GDF15 mRNA

NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055

G

glycerophosphodiester phosphodiesterase domain containing 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GDPD5 mRNA

NCBI chr 1:153,679,718...153,761,452
Ensembl chr 1:153,679,718...153,761,446

G

gliomedin

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GLDN mRNA

NCBI chr 8:54,679,015...54,723,198
Ensembl chr 8:54,679,119...54,723,196

G

GLIS family zinc finger 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GLIS2 mRNA

NCBI chr10:10,951,157...10,978,524
Ensembl chr10:10,951,371...10,971,578

G

G protein subunit alpha 14

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GNA14 mRNA

NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423

G

G protein subunit alpha transducin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GNAT1 mRNA

NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:108,350,935...108,355,671

G

golgi phosphoprotein 3-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GOLPH3L mRNA

NCBI chr 2:183,151,941...183,183,094
Ensembl chr 2:183,153,301...183,183,083

G

glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GPIHBP1 mRNA

NCBI chr 7:107,285,584...107,288,702
Ensembl chr 7:107,285,654...107,288,702

G

G protein-coupled receptor 146

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GPR146 mRNA

NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206

G

G protein-coupled receptor 162

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GPR162 mRNA

NCBI chr 4:157,662,200...157,668,341
Ensembl chr 4:157,662,200...157,668,121

G

G protein-coupled receptor, class C, group 5, member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GPRC5B mRNA

NCBI chr 1:173,316,904...173,340,933
Ensembl chr 1:173,316,907...173,340,932

G

GPRIN family member 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GPRIN3 mRNA

NCBI chr 4:88,572,062...88,657,369
Ensembl chr 4:88,563,607...88,657,429

G

glutathione peroxidase 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GPX7 mRNA

NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004

G

growth regulating estrogen receptor binding 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GREB1 mRNA

NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633

G

gremlin 2, DAN family BMP antagonist

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GREM2 mRNA

NCBI chr13:86,778,543...86,871,509
Ensembl chr13:86,778,500...86,871,615

G

gastrin releasing peptide

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GRP mRNA

NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061

G

glutathione S-transferase alpha 1

multiple interactions

GSTA1 protein affects the metabolism of and results in decreased susceptibility to 1,2,5,6-dibenzanthracene

NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121

G

glutathione S-transferase mu 1

multiple interactions

GSTM1 protein affects the metabolism of [1,2,5,6-dibenzanthracene co-treated with Glutathione]

NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411

G

glutathione S-transferase pi 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of GSTP1 mRNA

NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226

G

G-2 and S-phase expressed 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GTSE1 mRNA

NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806

G

guanylate cyclase 1 soluble subunit alpha 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of GUCY1A2 mRNA

NCBI chr 8:500,212...900,201
Ensembl chr 8:500,212...889,203

G

H1.2 linker histone, cluster member

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H1F2 mRNA

NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635

G

H1.5 linker histone, cluster member

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H1F5 mRNA

NCBI chr17:42,726,132...42,727,162
Ensembl chr17:42,726,127...42,769,160

G

H2A clustered histone 10

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC10 mRNA

NCBI chr17:41,570,532...41,571,020
Ensembl chr17:41,570,273...41,571,049

G

H2A clustered histone 12

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC12 mRNA

NCBI chr17:42,486,415...42,486,880
Ensembl chr17:42,486,415...42,486,941

G

H2A clustered histone 20

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC20 mRNA

NCBI chr 2:183,779,879...183,780,357

G

H2A clustered histone 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC4 mRNA

NCBI chr17:42,799,884...42,800,387
Ensembl chr17:42,799,652...42,800,381

G

H2A.X variant histone

increases expression

1,2,5,6-dibenzanthracene metabolite results in increased expression of H2AX protein

NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239

G

hepcidin antimicrobial peptide

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HAMP mRNA

NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891

G

hyaluronan and proteoglycan link protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HAPLN1 mRNA

NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777

G

histone deacetylase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HDAC1 mRNA

NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111

G

HEAT repeat containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HEATR1 mRNA

NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948

G

hephaestin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HEPH mRNA

NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980

G

HECT and RLD domain containing E3 ubiquitin protein ligase family member 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HERC6 mRNA

NCBI chr 4:87,524,470...87,566,895
Ensembl chr 4:87,524,493...87,581,744

G

hes-related family bHLH transcription factor with YRPW motif-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HEYL mRNA

NCBI chr 5:135,508,160...135,525,152
Ensembl chr 5:135,508,160...135,525,152

G

Hedgehog-interacting protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HHIP mRNA

NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528

G

HIC ZBTB transcriptional repressor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HIC1 mRNA

NCBI chr10:60,014,520...60,019,475
Ensembl chr10:60,011,528...60,019,475

G

hypoxia inducible factor 1 subunit alpha

increases activity
multiple interactions

1,2,5,6-dibenzanthracene results in increased activity of HIF1A protein
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HIF1A mRNA

PMID:17690111 PMID:19502547

NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261

G

hypoxia inducible lipid droplet-associated

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HILPDA mRNA

NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557

G

histone cluster 1 H2A family member H

increases expression

1,2,5,6-dibenzanthracene results in increased expression of H2AC11 mRNA; 1,2,5,6-dibenzanthracene results in increased expression of H2AC22 mRNA

NCBI chr17:41,384,521...41,385,018

G

hexokinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HK1 mRNA

NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131

G

hexokinase domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HKDC1 mRNA

NCBI chr20:30,335,322...30,373,792
Ensembl chr20:30,335,628...30,373,867

G

HLF transcription factor, PAR bZIP family member

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HLF mRNA

NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935

G

high mobility group box 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HMGB2 mRNA

NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140

G

high mobility group box 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HMGB3 mRNA

NCBI chr X:149,296,303...149,301,290
Ensembl chr X:149,296,375...149,301,292

G

3-hydroxy-3-methylglutaryl-CoA reductase

decreases expression
multiple interactions

1,2,5,6-dibenzanthracene results in decreased expression of HMGCR mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HMGCR mRNA

PMID:16269432 PMID:17690111

NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703

G

high mobility group nucleosomal binding domain 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HMGN2 mRNA

NCBI chr 5:146,192,126...146,195,580
Ensembl chr 5:146,192,126...146,195,521
Ensembl chr16:146,192,126...146,195,521

G

histamine N-methyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HNMT mRNA

NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012

G

homer scaffold protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HOMER2 mRNA

NCBI chr 1:135,558,977...135,659,780
Ensembl chr 1:135,567,414...135,659,772

G

hook microtubule-tethering protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HOOK2 mRNA

NCBI chr19:23,151,869...23,170,139
Ensembl chr19:23,151,870...23,164,181

G

15-hydroxyprostaglandin dehydrogenase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HPGD mRNA

NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228

G

hydroxysteroid 11-beta dehydrogenase 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of HSD11B1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of HSD11B1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HSD11B1 mRNA

NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687

G

heat shock protein family A (Hsp70) member 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HSPA1A mRNA

NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227

G

heat shock protein family A (Hsp70) member 4 like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HSPA4L mRNA

NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084

G

heat shock protein family H (Hsp110) member 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HSPH1 mRNA

NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224

G

hormonally upregulated Neu-associated kinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of HUNK mRNA

NCBI chr11:29,641,122...29,758,392
Ensembl chr11:29,640,775...29,757,526

G

Hydin, axonemal central pair apparatus protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of HYDIN mRNA

NCBI chr19:38,236,996...38,583,271
Ensembl chr19:38,236,464...38,583,264

G

inhibitor of DNA binding 1

multiple interactions
increases expression

[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ID1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ID1 mRNA
1,2,5,6-dibenzanthracene results in increased expression of ID1 mRNA

PMID:18711122 PMID:26377693

NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419

G

inhibitor of DNA binding 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ID2 mRNA

NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400

G

immediate early response 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IER3 mRNA

NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583

G

immediate early response 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IER5 mRNA

NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227

G

interferon, alpha-inducible protein 27 like 2A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IFI27L2A mRNA

NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360

G

insulin-like growth factor 1

increases expression
multiple interactions

1,2,5,6-dibenzanthracene results in increased expression of IGF1 mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGF1 mRNA

PMID:16269432 PMID:17690111

NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296

G

insulin-like growth factor 1 receptor

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IGF1R mRNA

NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777

G

insulin-like growth factor 2

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGF2 mRNA

NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018

G

insulin-like growth factor binding protein 1

increases expression
multiple interactions
decreases expression

1,2,5,6-dibenzanthracene results in increased expression of IGFBP1 mRNA
[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of IGFBP1 mRNA
1,2,5,6-dibenzanthracene results in decreased expression of IGFBP1 mRNA

PMID:16269432 PMID:17690111 PMID:26377693

NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482

G

insulin-like growth factor binding protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IGFBP2 mRNA

NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937

G

insulin-like growth factor binding protein 5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IGFBP5 mRNA

NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156

G

insulin-like growth factor binding protein 6

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IGFBP6 mRNA

NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966

G

IKAROS family zinc finger 4

affects expression

1,2,5,6-dibenzanthracene affects the expression of IKZF4 mRNA

NCBI chr 7:1,063,283...1,102,940
Ensembl chr 7:1,056,890...1,084,341

G

interleukin 18 receptor 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IL18R1 mRNA

NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715

G

interleukin 4 receptor

affects expression

1,2,5,6-dibenzanthracene affects the expression of IL4RA mRNA

NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980

G

inverted formin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of INF2 mRNA

NCBI chr 6:131,649,162...131,675,944
Ensembl chr 6:131,649,211...131,675,941

G

inhibin subunit beta B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of INHBB mRNA

NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832

G

inka box actin regulator 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of INKA2 mRNA

NCBI chr 2:193,185,275...193,200,643
Ensembl chr 2:193,185,275...193,200,642

G

insulin induced gene 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of INSIG2 mRNA

NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923

G

IQ motif containing GTPase activating protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of IQGAP3 mRNA

NCBI chr 2:173,542,151...173,583,956
Ensembl chr 2:173,542,110...173,583,956

G

insulin receptor substrate 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IRS1 mRNA

NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122

G

iroquois homeobox 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of IRX2 mRNA

NCBI chr 1:30,660,960...30,666,378
Ensembl chr 1:30,660,960...30,666,378

G

integrin subunit beta 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ITGB4 mRNA

NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012

G

integral membrane protein 2A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ITM2A mRNA

NCBI chr X:72,486,383...72,492,344
Ensembl chr X:72,486,381...72,492,363

G

inositol-trisphosphate 3-kinase A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of ITPKA mRNA

NCBI chr 3:106,726,036...106,734,601
Ensembl chr 3:106,726,036...106,734,600

G

jagged canonical Notch ligand 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of JAG2 mRNA

NCBI chr 6:131,983,059...132,005,665
Ensembl chr 6:131,983,056...132,005,818

G

junctional adhesion molecule 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of JAM2 mRNA

NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063

G

joining chain of multimeric IgA and IgM

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of JCHAIN mRNA

NCBI chr14:19,538,927...19,547,023
Ensembl chr14:19,538,952...19,546,298

G

KN motif and ankyrin repeat domains 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KANK4 mRNA

NCBI chr 5:113,401,491...113,465,526
Ensembl chr 5:113,402,468...113,465,555

G

kazrin, periplakin interacting protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KAZN mRNA

NCBI chr 5:154,392,793...155,381,567
Ensembl chr 5:154,392,793...154,779,074

G

potassium voltage-gated channel subfamily B member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNB1 mRNA

NCBI chr 3:155,820,255...155,913,383
Ensembl chr 3:155,822,963...155,916,194

G

potassium voltage-gated channel subfamily E regulatory subunit 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNE3 mRNA

NCBI chr 1:154,523,903...154,530,865
Ensembl chr 1:154,523,830...154,532,020

G

potassium calcium-activated channel subfamily N member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNN2 mRNA

NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347

G

potassium voltage-gated channel, modifier subfamily S, member 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCNS3 mRNA

NCBI chr 6:33,808,314...33,865,018
Ensembl chr 6:33,808,216...33,865,125

G

potassium channel tetramerization domain containing 12

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KCTD12 mRNA

NCBI chr15:79,800,078...79,806,017
Ensembl chr15:79,801,191...79,806,282

G

kinesin family member 20A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIF20A mRNA

NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780

G

kinesin family member 20B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIF20B mRNA

NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787

G

kinesin family member 22

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIF22 mRNA

NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401

G

kinesin family member 26B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KIF26B mRNA

NCBI chr13:90,282,821...90,689,058
Ensembl chr13:90,283,404...90,682,811

G

kinesin family member C1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KIFC1 mRNA

NCBI chr20:4,998,832...5,017,107
Ensembl chr20:4,999,047...5,017,105

G

KIT proto-oncogene receptor tyrosine kinase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KIT mRNA

NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652

G

KLF transcription factor 13

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KLF13 mRNA

NCBI chr 1:117,505,857...117,536,626
Ensembl chr 1:117,503,602...117,551,227

G

kelch-like family member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KLHL5 mRNA

NCBI chr14:43,144,254...43,206,192
Ensembl chr14:43,144,257...43,184,238

G

kallikrein related-peptidase 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of KLK8 mRNA

NCBI chr 1:94,251,803...94,258,646
Ensembl chr 1:94,251,803...94,258,646

G

kinetochore-localized astrin/SPAG5 binding protein

affects expression

1,2,5,6-dibenzanthracene affects the expression of KNSTRN mRNA

NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715

G

keratin 8

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of KRT8 mRNA

NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728

G

lymphocyte activating 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LAG3 mRNA

NCBI chr 4:157,712,665...157,722,229
Ensembl chr 4:157,712,667...157,720,404

G

laminin subunit alpha 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LAMA1 mRNA

NCBI chr 9:107,692,770...107,816,847
Ensembl chr 9:107,692,770...107,817,478

G

laminin subunit alpha 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LAMA2 mRNA

NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530

G

laminin subunit alpha 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LAMA4 mRNA

NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347

G

lipopolysaccharide binding protein

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of LBP mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of LBP mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of LBP mRNA

NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586

G

left right determination factor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LEFTY1 mRNA

NCBI chr13:92,649,226...92,659,722
Ensembl chr13:92,656,323...92,659,720

G

leptin receptor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LEPR mRNA

NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908

G

galectin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGALS1 mRNA

NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345

G

galectin 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGALS3 mRNA

NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025

G

galectin 9

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGALS9 mRNA

NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045

G

galectin-like

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LGALSL mRNA

NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980

G

leucine-rich repeat LGI family, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LGI2 mRNA

NCBI chr14:58,415,965...58,443,450
Ensembl chr14:58,415,965...58,443,407

G

LIF receptor subunit alpha

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LIFR mRNA

NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699

G

LIM domain only 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LMO2 mRNA

NCBI chr 3:90,355,234...90,377,970
Ensembl chr 3:90,365,883...90,377,953

G

ligand of numb-protein X 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LNX2 mRNA

NCBI chr12:8,005,202...8,070,494
Ensembl chr12:8,005,227...8,070,494

G

lysyl oxidase-like 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LOXL4 mRNA

NCBI chr 1:241,396,183...241,416,385
Ensembl chr 1:241,397,983...241,416,322

G

lipin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LPIN1 mRNA

NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097

G

lipoprotein lipase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LPL mRNA

NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249

G

lecithin retinol acyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LRAT mRNA

NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619

G

leucine rich repeat and fibronectin type III domain containing 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LRFN3 mRNA

NCBI chr 1:85,616,862...85,623,725
Ensembl chr 1:85,616,868...85,623,725

G

leucine rich repeat containing 36

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LRRC36 mRNA

NCBI chr19:33,292,074...33,342,426
Ensembl chr19:33,292,074...33,360,141

G

leucine rich repeat containing 75B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LRRC75B mRNA

NCBI chr20:13,100,302...13,106,503
Ensembl chr20:13,100,302...13,106,503

G

leukotriene B4 receptor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LTB4R1 mRNA

NCBI chr15:29,263,199...29,265,716

G

latent transforming growth factor beta binding protein 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LTBP2 mRNA

NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208

G

leukotriene C4 synthase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LTC4S mRNA

NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651

G

latexin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LXN mRNA

NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460

G

lymphocyte antigen 6 family member A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LY6A mRNA

NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981

G

LysM domain containing 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LYSMD2 mRNA

NCBI chr 8:76,378,984...76,394,396
Ensembl chr 8:76,379,219...76,394,654

G

LysM domain containing 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of LYSMD3 mRNA

NCBI chr 2:11,933,787...11,939,944
Ensembl chr 2:11,933,768...11,942,961

G

lymphatic vessel endothelial hyaluronan receptor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of LYVE1 mRNA

NCBI chr 1:164,962,872...164,976,309
Ensembl chr 1:164,962,872...164,976,309

G

mitotic arrest deficient 2 like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAD2L1 mRNA

NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470

G

mitotic arrest deficient 2 like 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MAD2L2 mRNA

NCBI chr 5:158,563,545...158,576,698
Ensembl chr 5:158,563,567...158,576,693

G

MAF bZIP transcription factor B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAFB mRNA

NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031

G

MAF bZIP transcription factor F

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAFF mRNA

NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851

G

mitogen-activated protein kinase kinase 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAP2K6 mRNA

NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293

G

mitogen-activated protein kinase kinase kinase 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAP3K6 mRNA

NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212

G

mitogen-activated protein kinase kinase kinase kinase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAP4K4 mRNA

NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698

G

microtubule-associated protein tau

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MAPT mRNA

NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129

G

myristoylated alanine rich protein kinase C substrate

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MARCKS mRNA

NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012

G

MARVEL domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MARVELD1 mRNA

NCBI chr 1:240,954,050...240,958,101
Ensembl chr 1:240,954,452...240,958,384

G

membrane bound O-acyltransferase domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MBOAT1 mRNA

NCBI chr17:34,331,413...34,445,088
Ensembl chr17:34,331,422...34,445,088

G

membrane bound O-acyltransferase domain containing 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MBOAT2 mRNA

NCBI chr 6:41,471,135...41,597,599
Ensembl chr 6:41,471,161...41,593,485

G

MCL1 apoptosis regulator, BCL2 family member

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of MCL1 mRNA

NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303

G

minichromosome maintenance complex component 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MCM2 mRNA

NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847

G

minichromosome maintenance complex component 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MCM3 mRNA

NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314

G

minichromosome maintenance complex component 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MCM6 mRNA

NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960

G

MDM2 proto-oncogene

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MDM2 mRNA

NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915

G

malic enzyme 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of ME1 mRNA

NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304

G

malic enzyme 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ME3 mRNA

NCBI chr 1:143,534,024...143,735,551
Ensembl chr 1:143,534,139...143,733,132

G

multiple EGF-like-domains 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MEGF6 mRNA

NCBI chr 5:164,738,272...164,839,142
Ensembl chr 5:164,738,352...164,839,139

G

O-6-methylguanine-DNA methyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MGMT mRNA

NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756

G

matrix Gla protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MGP mRNA

NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667

G

marker of proliferation Ki-67

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MKI67 mRNA

NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762

G

MAPK interacting serine/threonine kinase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MKNK2 mRNA

NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,039,728...9,050,827

G

melan-A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MLANA mRNA

NCBI chr 1:227,469,537...227,483,343
Ensembl chr 1:227,469,537...227,483,343

G

monocyte to macrophage differentiation-associated 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MMD2 mRNA

NCBI chr12:11,962,733...12,009,776
Ensembl chr12:11,962,757...12,009,773

G

matrix metallopeptidase 8

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MMP8 mRNA

NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520

G

multimerin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MMRN2 mRNA

NCBI chr16:9,705,925...9,727,405
Ensembl chr16:9,705,892...9,727,405

G

meiotic nuclear divisions 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MND1 mRNA

NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096

G

MORC family CW-type zinc finger 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MORC3 mRNA

NCBI chr11:33,151,906...33,194,650
Ensembl chr11:33,152,025...33,194,646

G

MAGUK p55 scaffold protein 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MPP4 mRNA

NCBI chr 9:60,569,734...60,613,035
Ensembl chr 9:60,569,734...60,611,797

G

MPV17 mitochondrial inner membrane protein like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MPV17L mRNA

NCBI chr10:1,988,451...2,025,300
Ensembl chr10:1,988,136...2,007,649

G

myelin protein zero-like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MPZL1 mRNA

NCBI chr13:77,852,467...77,889,305
Ensembl chr13:77,852,467...77,896,616

G

MAS related GPR family member E

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MRGPRE mRNA

NCBI chr 1:198,963,786...198,969,862
Ensembl chr 1:198,963,787...198,969,521

G

myoregulin

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MRLN mRNA

NCBI chr20:18,406,789...18,423,805
Ensembl chr20:18,406,707...18,428,418

G

mutS homolog 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MSH3 mRNA

NCBI chr 2:23,444,326...23,585,777

G

musashi RNA-binding protein 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MSI2 mRNA

NCBI chr10:73,143,760...73,510,566
Ensembl chr10:73,147,380...73,510,157

G

macrophage scavenger receptor 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MSR1 mRNA

NCBI chr16:52,717,775...52,803,602
Ensembl chr16:52,717,732...52,799,676

G

metallothionein 1, pseudogene 3

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of MT1E mRNA

NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135

G

methylenetetrahydrofolate reductase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MTHFR mRNA

NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797

G

myotubularin related protein 10

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MTMR10 mRNA

NCBI chr 1:117,859,355...117,910,839
Ensembl chr 1:117,859,267...117,910,849

G

melatonin receptor 1A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of MTNR1A mRNA

NCBI chr16:47,144,461...47,163,919
Ensembl chr16:47,144,461...47,163,919

G

MTSS I-BAR domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MTSS1 mRNA

NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968

G

musculoskeletal, embryonic nuclear protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MUSTN1 mRNA

NCBI chr16:6,072,908...6,075,161
Ensembl chr16:6,072,833...6,075,161

G

MYCN proto-oncogene, bHLH transcription factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of MYCN mRNA

NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590

G

nicotinamide phosphoribosyltransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NAMPT mRNA

NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100

G

nuclear prelamin A recognition factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NARF mRNA

NCBI chr10:106,519,508...106,537,494
Ensembl chr10:106,519,444...106,537,486

G

N-acetyltransferase 8 (GCN5-related) family member 5

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NAT8F5 mRNA

NCBI chr 4:118,260,323...118,285,038
Ensembl chr 4:118,260,252...118,285,704

G

non-SMC condensin I complex, subunit D2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NCAPD2 mRNA

NCBI chr 4:157,968,814...157,992,314
Ensembl chr 4:157,968,815...157,992,020

G

non-SMC condensin I complex, subunit H

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NCAPH mRNA

NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180

G

neutral cholesterol ester hydrolase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NCEH1 mRNA

NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588

G

NDC80 kinetochore complex component

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NDC80 mRNA

NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924

G

N-myc downstream regulated 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NDRG1 mRNA

NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880

G

nectin cell adhesion molecule 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NECTIN3 mRNA

NCBI chr11:54,362,712...54,469,351
Ensembl chr11:54,364,487...54,462,519

G

nestin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NES mRNA

NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777

G

neuroepithelial cell transforming 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NET1 mRNA

NCBI chr17:66,341,251...66,370,445
Ensembl chr17:66,340,728...66,370,441

G

nuclear factor, interleukin 3 regulated

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of NFIL3 mRNA

NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858

G

NFKB inhibitor alpha

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NFKBIA mRNA

NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941

G

neuronal guanine nucleotide exchange factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NGEF mRNA

NCBI chr 9:88,146,956...88,244,454
Ensembl chr 9:88,146,956...88,244,914

G

nerve growth factor receptor

decreases expression
increases expression

1,2,5,6-dibenzanthracene results in decreased expression of NGFR mRNA
1,2,5,6-dibenzanthracene results in increased expression of TNFRSF10B mRNA

PMID:16269432 PMID:26377693

NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518

G

NHL repeat containing 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NHLRC2 mRNA

NCBI chr 1:255,589,743...255,648,904
Ensembl chr 1:255,589,742...255,651,408

G

NKD inhibitor of WNT signaling pathway 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NKD1 mRNA

NCBI chr19:18,476,344...18,549,380
Ensembl chr19:18,476,344...18,549,380

G

nicotinamide riboside kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NMRK1 mRNA

NCBI chr 1:216,049,350...216,076,792
Ensembl chr 1:216,049,437...216,076,791

G

nitric oxide synthase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NOS3 mRNA

NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166

G

NADPH oxidase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NOX4 mRNA

NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406

G

neuropeptide Y receptor Y1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NPY1R mRNA

NCBI chr16:23,037,788...23,047,330
Ensembl chr16:23,037,789...23,046,759

G

NAD(P)H quinone dehydrogenase 1

increases expression
multiple interactions

1,2,5,6-dibenzanthracene results in increased expression of NQO1 mRNA
[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NQO1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NQO1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NQO1 mRNA

PMID:17253728 PMID:18711122

NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557

G

nuclear receptor subfamily 1, group D, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NR1D2 mRNA

NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553

G

nuclear receptor subfamily 5, group A, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NR5A2 mRNA

NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326

G

Notch-regulated ankyrin repeat protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NRARP mRNA

NCBI chr 3:7,992,582...7,995,136
Ensembl chr 3:7,992,552...7,995,133

G

neuronal regeneration related protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NREP mRNA

NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591

G

neuregulin 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NRG4 mRNA

NCBI chr 8:55,586,253...55,677,829
Ensembl chr 8:55,592,893...55,677,483

G

neurexin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NRXN1 mRNA

NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710

G

NSL1 component of MIS12 kinetochore complex

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NSL1 mRNA

NCBI chr13:102,649,050...102,674,059
Ensembl chr13:102,649,058...102,674,054

G

NUAK family kinase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NUAK2 mRNA

NCBI chr13:43,753,454...43,770,604
Ensembl chr13:43,753,832...43,770,604

G

nucleoporin 58

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NUP58 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUP58 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NUP58 mRNA

NCBI chr15:34,358,170...34,407,160
Ensembl chr15:34,358,277...34,407,060

G

nuclear protein 1, transcriptional regulator

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of NUPR1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of NUPR1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of NUPR1 mRNA

NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281

G

nucleolar and spindle associated protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of NUSAP1 mRNA

NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624

G

ornithine decarboxylase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ODC1 mRNA

NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440

G

olfactomedin-like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of OLFML1 mRNA

NCBI chr 1:161,478,129...161,502,541
Ensembl chr 1:161,478,242...161,502,537

G

one cut homeobox 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ONECUT1 mRNA

NCBI chr 8:75,599,432...75,633,598
Ensembl chr 8:75,599,740...75,627,277

G

oxysterol binding protein-like 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of OSBPL5 mRNA

NCBI chr 1:198,862,071...198,916,469
Ensembl chr 1:198,862,055...198,916,469

G

otopetrin 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of OTOP1 mRNA

NCBI chr14:72,505,036...72,532,497
Ensembl chr14:72,503,592...72,532,497

G

purinergic receptor P2X 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of P2RX7 mRNA

NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619

G

purinergic receptor P2Y1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of P2RY1 mRNA

NCBI chr 2:145,241,975...145,248,186
Ensembl chr 2:145,241,849...145,248,457

G

purinergic receptor P2Y2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of P2RY2 mRNA

NCBI chr 1:155,352,050...155,367,423
Ensembl chr 1:155,351,165...155,367,632

G

phenylalanine hydroxylase

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PAH mRNA

NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130

G

p21 (RAC1) activated kinase 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PAK3 mRNA

NCBI chr X:107,116,308...107,374,342
Ensembl chr X:107,260,898...107,368,314

G

palmdelphin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PALMD mRNA

NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519

G

PDZ binding kinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PBK mRNA

NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014

G

protocadherin 17

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCDH17 mRNA

NCBI chr15:60,222,088...60,316,172
Ensembl chr15:60,222,004...60,313,999

G

protocadherin alpha subfamily C, 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PCDHAC2 mRNA

Ensembl chr18:28,581,225...28,846,211

G

protocadherin beta 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PCDHB1 mRNA

NCBI chr18:28,913,835...28,916,746
Ensembl chr18:28,913,989...28,916,445

G

protocadherin beta 15

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCDHB7 mRNA

NCBI chr18:29,178,869...29,183,847
Ensembl chr18:29,181,052...29,183,804

G

proliferating cell nuclear antigen

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCNA mRNA

NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995

G

Purkinje cell protein 4-like 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCP4L1 mRNA

NCBI chr13:83,588,992...83,612,631
Ensembl chr13:83,588,992...83,609,966

G

proprotein convertase subtilisin/kexin type 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PCSK4 mRNA

NCBI chr 7:9,381,366...9,389,589
Ensembl chr 7:9,381,361...9,389,585

G

programmed cell death 6 interacting protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PDCD6IP protein

NCBI chr 8:113,590,998...113,646,795
Ensembl chr 8:113,590,998...113,646,773

G

phosphodiesterase 8B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PDE8B mRNA

NCBI chr 2:26,275,117...26,479,725
Ensembl chr 2:26,276,635...26,509,209

G

phosphodiesterase 9A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PDE9A mRNA

NCBI chr20:9,469,809...9,562,949
Ensembl chr20:9,469,848...9,562,948

G

platelet derived growth factor C

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PDGFC mRNA

NCBI chr 2:166,316,870...166,493,449
Ensembl chr 2:166,316,803...166,493,433

G

platelet derived growth factor D

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PDGFD mRNA

NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395

G

pyruvate dehydrogenase kinase 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PDK4 mRNA

NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850

G

platelet and endothelial cell adhesion molecule 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PECAM1 mRNA

NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116

G

period circadian regulator 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PER1 mRNA

NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431

G

period circadian regulator 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PER2 mRNA

NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459

G

period circadian regulator 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PER3 mRNA

NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607

G

peroxisomal biogenesis factor 26

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PEX26 mRNA

NCBI chr 4:154,414,332...154,426,954
Ensembl chr 4:154,414,849...154,426,952

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of PFKFB1 mRNA

NCBI chr X:19,508,522...19,562,165
Ensembl chr X:19,508,546...19,562,182

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PFKFB3 mRNA

NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125

G

pyroglutamyl-peptidase I

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PGPEP1 mRNA

NCBI chr16:18,770,563...18,782,968
Ensembl chr16:18,771,021...18,783,478

G

pleckstrin homology-like domain, family A, member 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PHLDA3 mRNA

NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335

G

phosphotyrosine interaction domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PID1 mRNA

NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044

G

piezo-type mechanosensitive ion channel component 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIEZO2 mRNA

NCBI chr18:56,468,449...56,844,984
Ensembl chr18:56,469,680...56,844,216

G

phosphoinositide-3-kinase regulatory subunit 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIK3R1 mRNA

NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631

G

Pim-1 proto-oncogene, serine/threonine kinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIM1 mRNA

NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174

G

PICALM interacting mitotic regulator

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PIMREG mRNA

NCBI chr10:56,669,603...56,674,540
Ensembl chr10:56,669,675...56,674,791

G

phosphatidylinositol transfer protein, cytoplasmic 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PITPNC1 mRNA

NCBI chr10:92,163,558...92,428,971
Ensembl chr10:92,167,196...92,429,297

G

cAMP-dependent protein kinase inhibitor gamma

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PKIG mRNA

NCBI chr 3:152,330,477...152,398,085
Ensembl chr 3:152,366,041...152,398,082

G

pyruvate kinase L/R

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PKLR mRNA

NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870

G

protein kinase N3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PKN3 mRNA

NCBI chr 3:13,350,082...13,363,572
Ensembl chr 3:13,335,041...13,363,567

G

phospholipase C, delta 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLCD4 mRNA

NCBI chr 9:76,115,523...76,158,602
Ensembl chr 9:76,117,168...76,142,453

G

phospholipase C, gamma 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLCG1 mRNA

NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330

G

phospholipase D family, member 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLD6 mRNA

NCBI chr10:44,578,536...44,581,187
Ensembl chr10:44,577,675...44,581,077

G

pleckstrin homology domain containing A7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLEKHA7 mRNA

NCBI chr 1:170,364,524...170,547,843
Ensembl chr 1:170,365,135...170,547,775

G

pleckstrin homology and RhoGEF domain containing G6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLEKHG6 mRNA

NCBI chr 4:158,163,443...158,182,628
Ensembl chr 4:158,162,969...158,182,271

G

perilipin 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PLIN2 mRNA

NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319

G

polo-like kinase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLK1 mRNA

NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400

G

polo-like kinase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLK2 mRNA

NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947

G

polo-like kinase 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLK5 mRNA

NCBI chr 7:9,346,777...9,367,923
Ensembl chr 7:9,346,777...9,355,196

G

phospholipid phosphatase 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPAP2A mRNA

NCBI chr 2:44,439,002...44,500,430
Ensembl chr 2:44,438,994...44,501,268

G

phospholipid phosphatase 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PLPP6 mRNA

NCBI chr 1:226,679,100...226,681,952
Ensembl chr 1:226,679,100...226,681,949

G

phorbol-12-myristate-13-acetate-induced protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PMAIP1 mRNA

NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429

G

patatin-like phospholipase domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PNPLA1 mRNA

NCBI chr20:6,917,993...6,952,157
Ensembl chr20:6,917,931...6,952,375

G

proline-rich nuclear receptor coactivator 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PNRC1 mRNA

NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161

G

POC1 centriolar protein A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of POC1A mRNA

NCBI chr 8:106,922,058...106,991,678
Ensembl chr 8:106,922,978...106,991,089

G

podocalyxin-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PODXL mRNA

NCBI chr 4:60,135,124...60,181,829
Ensembl chr 4:60,135,109...60,181,899

G

DNA polymerase epsilon, catalytic subunit

increases expression

1,2,5,6-dibenzanthracene results in increased expression of POLE mRNA

NCBI chr12:46,345,420...46,393,984
Ensembl chr12:46,345,420...46,393,939

G

DNA polymerase kappa

increases expression

1,2,5,6-dibenzanthracene results in increased expression of POLK mRNA

NCBI chr 2:27,822,228...27,882,331
Ensembl chr 2:27,822,679...27,882,313

G

cytochrome p450 oxidoreductase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of POR mRNA

NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245

G

peroxisome proliferator-activated receptor delta

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PPARD mRNA

NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968

G

phosphoribosyl pyrophosphate amidotransferase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPAT mRNA

NCBI chr14:31,215,741...31,250,144
Ensembl chr14:31,216,165...31,250,144

G

pro-platelet basic protein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PPBP mRNA

NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130

G

periplakin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPL mRNA

NCBI chr10:10,450,919...10,496,575
Ensembl chr10:10,450,919...10,496,575

G

protein phosphatase, Mg2+/Mn2+ dependent, 1F

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPM1F mRNA

NCBI chr11:84,064,422...84,094,410
Ensembl chr11:84,064,420...84,094,340

G

protein phosphatase 1, regulatory (inhibitor) subunit 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PPP1R2 mRNA

NCBI chr11:69,472,676...69,494,468
Ensembl chr11:69,472,555...69,494,463

G

protein phosphatase 1, regulatory subunit 3C

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PPP1R3C mRNA

NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961

G

protein regulator of cytokinesis 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRC1 mRNA

NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765

G

prolylcarboxypeptidase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRCP mRNA

NCBI chr 1:146,931,487...146,983,891
Ensembl chr 1:146,930,561...146,984,530

G

protein C receptor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PROCR mRNA

NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903

G

protein S

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PROS1 mRNA

NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286

G

proline rich 36

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PRR36 mRNA

NCBI chr12:2,560,533...2,567,766
Ensembl chr12:2,560,536...2,567,742

G

proline rich and Gla domain 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRRG3 mRNA

NCBI chr X:149,666,498...149,689,353
Ensembl chr X:149,670,257...149,677,373

G

serine protease 23

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PRSS23 mRNA

NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:143,401,396...143,422,091

G

serine protease 44

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PRSS44 mRNA

NCBI chr 8:110,791,698...110,805,303
Ensembl chr 8:110,791,698...110,805,303

G

prostaglandin I2 synthase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTGIS mRNA

NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451

G

prostaglandin reductase 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of PTGR1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of PTGR1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of PTGR1 mRNA

NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666

G

protein tyrosine phosphatase 4A1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTP4A1 mRNA

NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964

G

protein tyrosine phosphatase, non-receptor type 9

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PTPN9 mRNA

NCBI chr 8:57,391,290...57,472,352
Ensembl chr 8:57,391,259...57,470,952

G

protein tyrosine phosphatase, receptor type, G

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTPRG mRNA

NCBI chr15:12,871,706...13,552,186
Ensembl chr15:12,871,721...13,554,094

G

protein tyrosine phosphatase, receptor type, R

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTPRR mRNA

NCBI chr 7:51,662,595...51,929,605
Ensembl chr 7:51,662,595...51,929,603

G

pentraxin 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of PTX3 mRNA

NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323

G

peroxisomal membrane protein 4

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of PXMP4 mRNA

NCBI chr 3:143,093,371...143,110,620
Ensembl chr 3:143,093,018...143,110,651

G

RAB38, member RAS oncogene family

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RAB38 mRNA

NCBI chr 1:142,182,566...142,262,923
Ensembl chr 1:142,182,556...142,262,924

G

Rac GTPase-activating protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RACGAP1 mRNA

NCBI chr 7:130,750,936...130,780,891
Ensembl chr 7:130,750,936...130,780,831

G

RAD51 recombinase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAD51 mRNA

NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035

G

RAD52 homolog, DNA repair protein

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAD52 mRNA

NCBI chr 4:153,106,062...153,128,598
Ensembl chr 4:153,106,062...153,128,207

G

retinoic acid early transcript 1E

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RAET1E mRNA

NCBI chr 1:1,662,665...1,664,609
Ensembl chr 1:1,807,644...1,812,755

G

retinoic acid induced 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAI2 mRNA

NCBI chr X:32,948,656...33,011,222
Ensembl chr X:32,948,656...33,011,264

G

receptor activity modifying protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAMP3 mRNA

NCBI chr14:81,527,404...81,544,905
Ensembl chr14:81,527,385...81,544,902

G

Rap guanine nucleotide exchange factor 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RAPGEF4 mRNA

NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316

G

RASD family, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RASD2 mRNA

NCBI chr19:13,594,291...13,605,016
Ensembl chr19:13,594,291...13,605,016

G

RasGEF domain family, member 1B

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RASGEF1B mRNA

NCBI chr14:9,859,512...10,380,044
Ensembl chr14:9,860,247...10,379,741

G

RAS protein-specific guanine nucleotide-releasing factor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RASGRF2 mRNA

NCBI chr 2:23,113,613...23,361,537
Ensembl chr 2:23,117,004...23,361,240

G

RAS guanyl releasing protein 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RASGRP3 mRNA

NCBI chr 6:19,895,361...19,993,945
Ensembl chr 6:19,895,390...19,958,578

G

RNA binding motif protein 47

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RBM47 mRNA

NCBI chr14:42,053,290...42,191,572
Ensembl chr14:42,154,142...42,189,431

G

regulator of calcineurin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RCAN1 mRNA

NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045

G

RCSD domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RCSD1 mRNA

NCBI chr13:77,901,898...77,964,309
Ensembl chr13:77,901,898...77,966,228

G

RecQ like helicase

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RECQL mRNA

NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945

G

receptor accessory protein 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of REEP1 mRNA

NCBI chr 4:103,746,004...103,862,347
Ensembl chr 4:103,745,633...103,862,338

G

refilin B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RFLNB mRNA

NCBI chr10:60,893,693...60,899,970
Ensembl chr10:60,893,713...60,899,976

G

regulator of cell cycle

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGCC mRNA

NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141

G

regulator of G-protein signaling 12

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGS12 mRNA

NCBI chr14:75,715,925...75,824,012
Ensembl chr14:75,715,934...75,794,596

G

regulator of G-protein signaling 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGS3 mRNA

NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894

G

regulator of G-protein signaling 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RGS5 mRNA

NCBI chr13:81,848,254...81,885,053
Ensembl chr13:81,836,304...81,885,518

G

ras homolog family member B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RHOB mRNA

NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108

G

ras homolog family member C

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RHOC mRNA

PMID:22579512 PMID:26377693

NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306

G

ras homolog family member U

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RHOU mRNA

NCBI chr19:51,641,476...51,651,249
Ensembl chr19:51,641,227...51,650,552

G

ribonuclease A family member 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNASE2A mRNA

NCBI chr15:24,449,618...24,450,427
Ensembl chr15:24,449,611...24,450,479

G

ribonuclease H2, subunit B

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RNASEH2B mRNA

NCBI chr15:36,541,200...36,592,016
Ensembl chr15:36,541,218...36,584,118

G

Rho family GTPase 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RND1 mRNA

NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399

G

ring finger protein 125

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF125 mRNA

NCBI chr18:12,254,066...12,275,719
Ensembl chr18:12,253,852...12,275,983

G

ring finger protein 128

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF128 mRNA

NCBI chr X:103,183,643...103,298,431
Ensembl chr X:103,183,831...103,298,423

G

ring finger protein 144A

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF144A mRNA

NCBI chr 6:42,899,767...43,019,769
Ensembl chr 6:42,903,174...43,020,012

G

ring finger protein 167

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RNF167 mRNA

NCBI chr10:55,360,603...55,364,927
Ensembl chr10:55,360,543...55,364,927

G

ring finger protein 169

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RNF169 mRNA

NCBI chr 1:154,250,462...154,311,867
Ensembl chr 1:154,254,473...154,311,653

G

ring finger protein 186

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RNF186 mRNA

NCBI chr 5:151,210,492...151,211,716
Ensembl chr 5:151,210,492...151,211,716

G

roundabout guidance receptor 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ROBO2 mRNA

NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536

G

ribosomal protein L39 like 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RPL39L mRNA

NCBI chr10:5,455,712...5,459,828
Ensembl chr10:5,454,559...5,462,029

G

ribosomal protein S27-like

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RPS27L mRNA

NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418

G

RRAD, Ras related glycolysis inhibitor and calcium channel regulator

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of RRAD mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of RRAD mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of RRAD mRNA

NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417

G

ribonucleotide reductase catalytic subunit M1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RRM1 mRNA

NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261

G

ribonucleotide reductase regulatory subunit M2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RRM2 mRNA

NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773

G

RRN3 homolog, RNA polymerase I transcription factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RRN3 mRNA

NCBI chr10:2,129,949...2,165,381
Ensembl chr10:2,129,978...2,165,663

G

arginine and serine rich protein 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RSRP1 mRNA

NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523

G

retrotransposon Gag like 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RTL6 mRNA

NCBI chr 7:115,684,812...115,689,897
Ensembl chr 7:115,684,739...115,690,052

G

retrotransposon Gag like 8A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of RTL8A mRNA

NCBI chr X:133,414,027...133,415,240
Ensembl chr X:133,414,030...133,415,240

G

RUN and FYVE domain containing 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of RUFY3 mRNA

NCBI chr14:19,431,530...19,506,476
Ensembl chr14:19,432,524...19,507,004

G

S100 calcium binding protein A10

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of S100A10 mRNA

NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661

G

S100 calcium binding protein A14

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of S100A14 mRNA

NCBI chr 2:176,008,395...176,010,423
Ensembl chr 2:176,008,395...176,010,423

G

SAC3 domain containing 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SAC3D1 mRNA

NCBI chr 1:203,414,184...203,416,563
Ensembl chr 1:203,414,187...203,416,604

G

sterile alpha motif domain containing 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SAMD5 mRNA

NCBI chr 1:4,041,547...4,090,909
Ensembl chr 1:3,677,784...4,091,120

G

spermidine/spermine N1-acetyl transferase 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SAT1 mRNA

NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813

G

stearoyl-CoA desaturase

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SCD mRNA

NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562

G

secretoglobin, family 3A, member 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SCGB3A1 mRNA

NCBI chr10:33,968,059...33,969,366
Ensembl chr10:33,968,059...33,969,476

G

sodium voltage-gated channel beta subunit 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SCN1B mRNA

NCBI chr 1:86,353,917...86,363,820
Ensembl chr 1:86,353,917...86,363,739

G

sodium voltage-gated channel beta subunit 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SCN3B mRNA

NCBI chr 8:40,630,372...40,652,869
Ensembl chr 8:40,630,455...40,652,868

G

signal peptide, CUB domain and EGF like domain containing 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SCUBE3 mRNA

NCBI chr20:6,199,182...6,231,100
Ensembl chr20:6,199,182...6,228,584

G

selenoprotein I

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SELENOI mRNA

NCBI chr 6:26,073,127...26,111,326
Ensembl chr 6:26,072,648...26,111,314

G

semaphorin 3C

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SEMA3C mRNA

NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534

G

semaphorin 3G

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SEMA3G mRNA

NCBI chr16:6,413,589...6,425,221
Ensembl chr16:6,413,589...6,425,221

G

stress-associated endoplasmic reticulum protein family member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERP2 mRNA

NCBI chr15:51,879,882...51,903,958
Ensembl chr15:51,879,877...51,904,785

G

serpin family A member 3N

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SERPINA3 mRNA

NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433

G

serpin family B member 1A

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINB1A mRNA

NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102

G

serpin family D member 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of SERPIND1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SERPIND1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SERPIND1 mRNA

NCBI chr11:83,664,517...83,675,593
Ensembl chr11:83,664,518...83,675,519

G

serpin family E member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINE1 mRNA

NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657

G

serpin family E member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SERPINE2 mRNA

NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826

G

sestrin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SESN2 mRNA

NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260

G

shugoshin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SGO1 mRNA

NCBI chr 9:6,672,109...6,687,908
Ensembl chr 9:6,672,123...6,687,805

G

SH3 domain containing GRB2 like 3, endophilin A3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SH3GL3 mRNA

NCBI chr 1:136,124,500...136,255,669
Ensembl chr 1:136,124,499...136,255,584

G

SHC binding and spindle associated 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SHCBP1 mRNA

NCBI chr16:84,672,277...84,703,843
Ensembl chr16:84,672,321...84,703,844

G

siah E3 ubiquitin protein ligase 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SIAH2 mRNA

NCBI chr 2:142,913,924...142,931,752
Ensembl chr 2:142,914,003...142,931,950

G

SIX homeobox 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SIX1 mRNA

NCBI chr 6:91,746,739...91,751,975
Ensembl chr 6:91,746,739...91,751,975

G

spindle and kinetochore associated complex subunit 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SKA1 mRNA

NCBI chr18:67,794,722...67,805,037
Ensembl chr18:67,794,725...67,805,037

G

solute carrier family 10 member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC10A2 mRNA

NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475

G

solute carrier family 13 member 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SLC13A2 mRNA

NCBI chr10:63,291,813...63,319,127
Ensembl chr10:63,291,815...63,319,127

G

solute carrier family 13 member 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC13A4 mRNA

NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857

G

solute carrier family 16 member 1

multiple interactions

[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of SLC16A1 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of SLC16A1 mRNA; [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SLC16A1 mRNA

NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611

G

solute carrier family 16 member 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC16A5 mRNA

NCBI chr10:100,707,434...100,721,338
Ensembl chr10:100,707,434...100,721,338

G

solute carrier family 16 member 7

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC16A7 mRNA

NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994

G

solute carrier family 17, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC17A2 mRNA

NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325

G

solute carrier family 19 member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC19A2 mRNA

NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172

G

solute carrier family 25 member 33

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC25A33 mRNA

NCBI chr 5:160,195,040...160,219,961
Ensembl chr 5:160,195,042...160,219,961

G

solute carrier family 25, member 34

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC25A34 mRNA

NCBI chr 5:153,932,081...153,936,854

G

solute carrier family 25 member 37

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SLC25A37 mRNA

NCBI chr15:44,534,280...44,576,697
Ensembl chr15:44,536,727...44,577,199

G

solute carrier family 29 member 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC29A4 mRNA

NCBI chr12:11,853,540...11,884,660
Ensembl chr12:11,853,540...11,874,834

G

solute carrier family 2 member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC2A1 mRNA

NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416

G

solute carrier family 2 member 9

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC2A9 mRNA

NCBI chr14:72,328,334...72,461,981
Ensembl chr14:72,328,320...72,461,981

G

solute carrier family 30 member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC30A1 mRNA

NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910

G

solute carrier family 30, member 10

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SLC30A10 mRNA

NCBI chr13:96,998,143...97,048,076
Ensembl chr13:96,998,143...97,009,103

G

solute carrier family 36 member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC36A2 mRNA

NCBI chr10:39,278,002...39,306,082
Ensembl chr10:39,278,046...39,306,082

G

solute carrier family 39 member 14

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC39A14 mRNA

NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524

G

solute carrier family 43 member 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC43A1 mRNA

NCBI chr 3:69,920,586...69,946,768
Ensembl chr 3:69,920,649...69,946,768

G

solute carrier family 4 member 1 (Diego blood group)

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SLC4A1 mRNA

NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117

G

solute carrier family 5 member 12

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SLC5A12 mRNA

NCBI chr 3:97,179,326...97,228,405
Ensembl chr 3:97,179,326...97,228,405

G

solute carrier family 5 member 6

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC5A6 mRNA

NCBI chr 6:25,319,187...25,331,713
Ensembl chr 6:25,320,442...25,331,712

G

solute carrier family 6 member 14

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLC6A14 mRNA

NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096

G

solute carrier organic anion transporter family, member 2b1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SLCO2B1 mRNA

NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353

G

SMAD family member 3

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SMAD3 mRNA

NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960

G

small cell adhesion glycoprotein

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SMAGP mRNA

NCBI chr 7:131,720,260...131,738,711
Ensembl chr 7:131,718,740...131,738,691

G

SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SMARCA2 mRNA

NCBI chr 1:224,191,125...224,358,640
Ensembl chr 1:224,191,125...224,358,684

G

synuclein alpha

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SNCA mRNA

NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262

G

synuclein, gamma

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SNCG mRNA

NCBI chr16:9,700,513...9,705,751
Ensembl chr16:9,700,514...9,705,368

G

suppressor of cytokine signaling 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SOCS2 mRNA

NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548

G

sorbin and SH3 domain containing 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SORBS3 mRNA

NCBI chr15:45,252,921...45,284,758
Ensembl chr15:45,253,379...45,284,758

G

SRY-box transcription factor 9

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SOX9 mRNA

NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994

G

Sp8 transcription factor

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SP8 mRNA

NCBI chr 6:139,816,258...139,818,865
Ensembl chr 6:139,814,819...139,823,168
Ensembl chr 6:139,814,819...139,823,168

G

SPC25 component of NDC80 kinetochore complex

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SPC25 mRNA

NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959

G

serine peptidase inhibitor, Kunitz type 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SPINT1 mRNA

NCBI chr 3:106,231,082...106,244,121
Ensembl chr 3:106,231,444...106,244,119

G

spondin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SPON1 mRNA

NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226

G

spondin 2

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SPON2 mRNA

NCBI chr14:77,505,695...77,518,001
Ensembl chr14:77,511,901...77,517,996

G

secreted phosphoprotein 1

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SPP1 mRNA

PMID:17690111 PMID:18711122

NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162

G

splA/ryanodine receptor domain and SOCS box containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SPSB1 mRNA

NCBI chr 5:160,358,292...160,418,541
Ensembl chr 5:160,358,308...160,418,468

G

spectrin, beta, non-erythrocytic 2

multiple interactions

[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SPTBN2 mRNA

NCBI chr 1:202,002,970...202,045,343
Ensembl chr 1:202,002,970...202,044,283

G

SLIT-ROBO Rho GTPase activating protein 3

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of SRGAP3 mRNA

NCBI chr 4:145,839,369...146,070,556
Ensembl chr 4:145,840,078...146,070,575

G

serglycin

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SRGN mRNA

NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406

G

sarcospan

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SSPN mRNA

NCBI chr 4:178,890,030...178,946,267
Ensembl chr 4:178,897,147...178,931,554

G

ST3 beta-galactoside alpha-2,3-sialyltransferase 5

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ST3GAL5 mRNA

NCBI chr 4:104,134,613...104,192,558
Ensembl chr 4:104,134,613...104,192,558

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ST6GALNAC4 mRNA

NCBI chr 3:15,872,230...15,885,250
Ensembl chr 3:15,872,532...15,885,243

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4

increases expression

1,2,5,6-dibenzanthracene results in increased expression of ST8SIA4 mRNA

NCBI chr 9:95,990,131...96,084,661
Ensembl chr 9:95,993,503...96,084,653

G

stabilin 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of STAB2 mRNA

NCBI chr 7:21,249,426...21,433,051
Ensembl chr 7:21,249,391...21,434,042

G

StAR-related lipid transfer domain containing 13

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of STARD13 mRNA

NCBI chr12:566,282...959,372
Ensembl chr12:566,310...959,421

G

serine/threonine kinase 35

increases expression

1,2,5,6-dibenzanthracene results in increased expression of STK35 mRNA

NCBI chr 3:117,016,819...117,049,131
Ensembl chr 3:117,016,950...117,048,066

G

stathmin 1

increases expression

1,2,5,6-dibenzanthracene results in increased expression of STMN1 mRNA

NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154

G

stathmin domain containing 1

decreases expression

1,2,5,6-dibenzanthracene results in decreased expression of STMND1 mRNA

NCBI chr17:18,393,312...18,420,655
Ensembl chr17:18,394,346...18,437,412

G

sulfatase 2

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SULF2 mRNA

NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:154,822,085...154,904,415

G

Sad1 and UNC84 domain containing 3

increases expression

1,2,5,6-dibenzanthracene results in increased expression of SUN3 mRNA